Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
Attorneys for bankrupt drugmaker Avadel Specialty Pharmaceuticals LLC said Tuesday that a combined hearing on its Chapter 11 plan and disclosure statement would have to wait after the Internal Revenue Service filed a $50 million claim against the estate related to outstanding tax liabilities.
Corcept Therapeutics Inc. has asked a New Jersey federal judge to block Sun Pharma's planned generic version of its flagship Cushing's syndrome medication Korlym, claiming three valid patents will be infringed.
Amgen and Allergan have started selling their biosimilar versions of Genentech's blockbuster cancer treatments Avastin and Herceptin in the U.S., announcing the launch immediately after a Delaware federal judge refused to block the sales.
A consumer behavior expert testified Monday that a "propaganda analysis" he conducted on hundreds of Johnson & Johnson marketing materials showed that they would have misled consumers by downplaying the risks of surgical mesh devices, during California's trial alleging the industry titan falsely marketed the mesh products.
Indivior has urged a federal judge to toss an indictment accusing it of misrepresenting the risk of abuse posed to children by its opioid-dependence treatment Suboxone Film, claiming federal prosecutors included inadmissible references to a doctor's health care fraud convictions and possibly even intentionally misled the grand jury.